ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q3Scopus Q3SCImago #11,918Hybrid

Current Pharmacology Reports

Identifier (ISSN):2198-641X(Print)
•
Publisher:Springer Nature
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
1.8↓ -0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Current Pharmacology Reports

WoS Q3
0123020232.220251.82026
Annual Impact Factor Metric
Current (2026):1.8
Scopus SJR & RankScopus Q3
0.499
#11,918

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
43

43 papers with at least that number of citations each

WoS: ESCIQ3
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
0articles/year
10.08% Gold OA•0% Original Research

Aims & Scope

Current Pharmacology Reports will: publish cutting-edge reviews on subjects pertinent to all aspects of pharmacology, including drug discovery and development.provide incisive, insightful, and balanced contributions from international leading experts.interest a wide readership of basic scientists and translational investigators in academia and in industry. The Current Pharmacology Reports journal accomplishes its goal by appointing international authorities to serve as Section Editors in key subject areas, such as: epigenetics and epigenomics, chemoinformatics and rational drug design and target discovery, drug delivery and biomaterial, pharmacogenomics and molecular targets and biomarkers, chemical/drug/molecular toxicology, absorption, distribution, metabolism and elimination (ADME), pharmacokinetics (PK) and pharmacodynamics (PD), Modeling & Simulation (M&S) and pharmacometrics, and other related topics in pharmacology including neurology/central nervous system (CNS), cardiovascular, metabolic diseases, cancer, among others. Section Editors for Current Pharmacology Reports select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided. This journal publishes on a bi-monthly schedule.Please submit here: https://www.editorialmanager.com/phar/default.aspx

Topics Covered (Recognized by AI)
Biology97%Medicine94.7%Internal medicine83.4%Genetics80.1%Chemistry79.8%Biochemistry75.5%Cancer46.4%Gene44.7%Pharmacology38.4%Pathology36.8%Bioinformatics35.1%Endocrinology29.8%Organic chemistry27.8%Cancer research27.2%Apoptosis26.2%Psychology25.2%Immunology24.2%Cell23.5%Disease21.9%Psychiatry20.9%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

PHARMACOLOGY & PHARMACY

Q3
Rank258/356
IndexESCI
JCIESCI2026

PHARMACOLOGY & PHARMACY

Q4
Rank302/356
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.8
Articles / Year35
Total Citations15
2025
IF2.2
Articles / Year50
Total Citations175
2024
IF—
Articles / Year37
Total Citations166
2023
IF0
Articles / Year41
Total Citations247
2022
IF—
Articles / Year38
Total Citations645

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #11,918Scopus Q3SCImago Profile
Scopus Coverage:2015-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.499

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
2.14

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,991 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations321
3-Year Documents109
Citable Documents109

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiochemistryQ3
Drug DiscoveryQ3
GeneticsQ3
PharmacologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Current Pharmacology Reports (ISSN: 2198-641X) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by Springer Nature in Switzerland. The periodical holds a Journal Impact Factor (JIF) of 1.80, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.499 (Q3), an H-index of 43.

The journal enforces rigorous peer evaluation with a publication frequency of 6 issues per year, an annual output of approximately 0 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,991 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Nature
Publication Language
English
Frequency
6 issues per year
Indexing & Databases
ScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: e894a962-5687-4a26-b1a4-632cffd6e6fa
Database Updated: 2026-09-30